aluates Reports

$ 0.0

Automative

Global Ocular Gene Therapy Market Research Report 2024

Published Date: May 2024

Report Code: QYRE-Auto-39G17214

BUY CHAPTERS

Global Ocular Gene Therapy Market Research Report 2024

Code: QYRE-Auto-39G17214

Report

May 2024

Pages:73

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Companies

AbbVie

REGENXBIO

GenSight Biologics

Astellas

MeriaGTx

Neurophth Therapeutics

Innostellar Biotherapeutics

Exegenesis Bio

Zhongyin Technology

Ocular Gene Therapy Market

The global Ocular Gene Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Ocular Gene Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Ocular Gene Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Ocular Gene Therapy in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Ocular Gene Therapy include AbbVie, MeriaGTx, Regenxbio, GenSight Biologics, Astellas, Neurophth Therapeutics, Innostellar Biotherapeutics, Exegenesis Bio, Zhongyin Technology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Ocular Gene Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ocular Gene Therapy.

The Ocular Gene Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ocular Gene Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Ocular Gene Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Ocular Gene Therapy Market Report

Report Metric	Details
Report Name	Ocular Gene Therapy Market
Segment by Type	Gene Replacement Technology Gene Editing Technology Others
Segment by Application	Hospitals Diagnostics Centers Research Institutes
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, MeriaGTx, Regenxbio, GenSight Biologics, Astellas, Neurophth Therapeutics, Innostellar Biotherapeutics, Exegenesis Bio, Zhongyin Technology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ocular Gene Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Ocular Gene Therapy Market report?

Ans: The main players in the Ocular Gene Therapy Market are AbbVie, MeriaGTx, Regenxbio, GenSight Biologics, Astellas, Neurophth Therapeutics, Innostellar Biotherapeutics, Exegenesis Bio, Zhongyin Technology

What are the Application segmentation covered in the Ocular Gene Therapy Market report?

Ans: The Applications covered in the Ocular Gene Therapy Market report are Hospitals, Diagnostics Centers, Research Institutes

What are the Type segmentation covered in the Ocular Gene Therapy Market report?

Ans: The Types covered in the Ocular Gene Therapy Market report are Gene Replacement Technology, Gene Editing Technology, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Ocular Gene Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Gene Replacement Technology

1.2.3 Gene Editing Technology

1.2.4 Others

1.3 Market by Application

1.3.1 Global Ocular Gene Therapy Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Diagnostics Centers

1.3.4 Research Institutes

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Ocular Gene Therapy Market Perspective (2019-2030)

2.2 Global Ocular Gene Therapy Growth Trends by Region

2.2.1 Global Ocular Gene Therapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Ocular Gene Therapy Historic Market Size by Region (2019-2024)

2.2.3 Ocular Gene Therapy Forecasted Market Size by Region (2025-2030)

2.3 Ocular Gene Therapy Market Dynamics

2.3.1 Ocular Gene Therapy Industry Trends

2.3.2 Ocular Gene Therapy Market Drivers

2.3.3 Ocular Gene Therapy Market Challenges

2.3.4 Ocular Gene Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Ocular Gene Therapy Players by Revenue

3.1.1 Global Top Ocular Gene Therapy Players by Revenue (2019-2024)

3.1.2 Global Ocular Gene Therapy Revenue Market Share by Players (2019-2024)

3.2 Global Ocular Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Ocular Gene Therapy Revenue

3.4 Global Ocular Gene Therapy Market Concentration Ratio

3.4.1 Global Ocular Gene Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Ocular Gene Therapy Revenue in 2023

3.5 Global Key Players of Ocular Gene Therapy Head office and Area Served

3.6 Global Key Players of Ocular Gene Therapy, Product and Application

3.7 Global Key Players of Ocular Gene Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Ocular Gene Therapy Breakdown Data by Type

4.1 Global Ocular Gene Therapy Historic Market Size by Type (2019-2024)

4.2 Global Ocular Gene Therapy Forecasted Market Size by Type (2025-2030)

5 Ocular Gene Therapy Breakdown Data by Application

5.1 Global Ocular Gene Therapy Historic Market Size by Application (2019-2024)

5.2 Global Ocular Gene Therapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Ocular Gene Therapy Market Size (2019-2030)

6.2 North America Ocular Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Ocular Gene Therapy Market Size by Country (2019-2024)

6.4 North America Ocular Gene Therapy Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Ocular Gene Therapy Market Size (2019-2030)

7.2 Europe Ocular Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Ocular Gene Therapy Market Size by Country (2019-2024)

7.4 Europe Ocular Gene Therapy Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Ocular Gene Therapy Market Size (2019-2030)

8.2 Asia-Pacific Ocular Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Ocular Gene Therapy Market Size by Region (2019-2024)

8.4 Asia-Pacific Ocular Gene Therapy Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Ocular Gene Therapy Market Size (2019-2030)

9.2 Latin America Ocular Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Ocular Gene Therapy Market Size by Country (2019-2024)

9.4 Latin America Ocular Gene Therapy Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Ocular Gene Therapy Market Size (2019-2030)

10.2 Middle East & Africa Ocular Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Ocular Gene Therapy Market Size by Country (2019-2024)

10.4 Middle East & Africa Ocular Gene Therapy Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AbbVie

11.1.1 AbbVie Company Details

11.1.2 AbbVie Business Overview

11.1.3 AbbVie Ocular Gene Therapy Introduction

11.1.4 AbbVie Revenue in Ocular Gene Therapy Business (2019-2024)

11.1.5 AbbVie Recent Development

11.2 MeriaGTx

11.2.1 MeriaGTx Company Details

11.2.2 MeriaGTx Business Overview

11.2.3 MeriaGTx Ocular Gene Therapy Introduction

11.2.4 MeriaGTx Revenue in Ocular Gene Therapy Business (2019-2024)

11.2.5 MeriaGTx Recent Development

11.3 Regenxbio

11.3.1 Regenxbio Company Details

11.3.2 Regenxbio Business Overview

11.3.3 Regenxbio Ocular Gene Therapy Introduction

11.3.4 Regenxbio Revenue in Ocular Gene Therapy Business (2019-2024)

11.3.5 Regenxbio Recent Development

11.4 GenSight Biologics

11.4.1 GenSight Biologics Company Details

11.4.2 GenSight Biologics Business Overview

11.4.3 GenSight Biologics Ocular Gene Therapy Introduction

11.4.4 GenSight Biologics Revenue in Ocular Gene Therapy Business (2019-2024)

11.4.5 GenSight Biologics Recent Development

11.5 Astellas

11.5.1 Astellas Company Details

11.5.2 Astellas Business Overview

11.5.3 Astellas Ocular Gene Therapy Introduction

11.5.4 Astellas Revenue in Ocular Gene Therapy Business (2019-2024)

11.5.5 Astellas Recent Development

11.6 Neurophth Therapeutics

11.6.1 Neurophth Therapeutics Company Details

11.6.2 Neurophth Therapeutics Business Overview

11.6.3 Neurophth Therapeutics Ocular Gene Therapy Introduction

11.6.4 Neurophth Therapeutics Revenue in Ocular Gene Therapy Business (2019-2024)

11.6.5 Neurophth Therapeutics Recent Development

11.7 Innostellar Biotherapeutics

11.7.1 Innostellar Biotherapeutics Company Details

11.7.2 Innostellar Biotherapeutics Business Overview

11.7.3 Innostellar Biotherapeutics Ocular Gene Therapy Introduction

11.7.4 Innostellar Biotherapeutics Revenue in Ocular Gene Therapy Business (2019-2024)

11.7.5 Innostellar Biotherapeutics Recent Development

11.8 Exegenesis Bio

11.8.1 Exegenesis Bio Company Details

11.8.2 Exegenesis Bio Business Overview

11.8.3 Exegenesis Bio Ocular Gene Therapy Introduction

11.8.4 Exegenesis Bio Revenue in Ocular Gene Therapy Business (2019-2024)

11.8.5 Exegenesis Bio Recent Development

11.9 Zhongyin Technology

11.9.1 Zhongyin Technology Company Details

11.9.2 Zhongyin Technology Business Overview

11.9.3 Zhongyin Technology Ocular Gene Therapy Introduction

11.9.4 Zhongyin Technology Revenue in Ocular Gene Therapy Business (2019-2024)

11.9.5 Zhongyin Technology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Companies

AbbVie

REGENXBIO

GenSight Biologics

Astellas

MeriaGTx

Neurophth Therapeutics

Innostellar Biotherapeutics

Exegenesis Bio

Zhongyin Technology

List of Tables

Table 1. Global Ocular Gene Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Gene Replacement Technology

Table 3. Key Players of Gene Editing Technology

Table 4. Key Players of Others

Table 5. Global Ocular Gene Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Ocular Gene Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Ocular Gene Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Ocular Gene Therapy Market Share by Region (2019-2024)

Table 9. Global Ocular Gene Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Ocular Gene Therapy Market Share by Region (2025-2030)

Table 11. Ocular Gene Therapy Market Trends

Table 12. Ocular Gene Therapy Market Drivers

Table 13. Ocular Gene Therapy Market Challenges

Table 14. Ocular Gene Therapy Market Restraints

Table 15. Global Ocular Gene Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Ocular Gene Therapy Market Share by Players (2019-2024)

Table 17. Global Top Ocular Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ocular Gene Therapy as of 2023)

Table 18. Ranking of Global Top Ocular Gene Therapy Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Ocular Gene Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Ocular Gene Therapy, Headquarters and Area Served

Table 21. Global Key Players of Ocular Gene Therapy, Product and Application

Table 22. Global Key Players of Ocular Gene Therapy, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Ocular Gene Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Ocular Gene Therapy Revenue Market Share by Type (2019-2024)

Table 26. Global Ocular Gene Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Ocular Gene Therapy Revenue Market Share by Type (2025-2030)

Table 28. Global Ocular Gene Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Ocular Gene Therapy Revenue Market Share by Application (2019-2024)

Table 30. Global Ocular Gene Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Ocular Gene Therapy Revenue Market Share by Application (2025-2030)

Table 32. North America Ocular Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Ocular Gene Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Ocular Gene Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Ocular Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Ocular Gene Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Ocular Gene Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Ocular Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Ocular Gene Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Ocular Gene Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Ocular Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Ocular Gene Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Ocular Gene Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Ocular Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Ocular Gene Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Ocular Gene Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 47. AbbVie Company Details

Table 48. AbbVie Business Overview

Table 49. AbbVie Ocular Gene Therapy Product

Table 50. AbbVie Revenue in Ocular Gene Therapy Business (2019-2024) & (US$ Million)

Table 51. AbbVie Recent Development

Table 52. MeriaGTx Company Details

Table 53. MeriaGTx Business Overview

Table 54. MeriaGTx Ocular Gene Therapy Product

Table 55. MeriaGTx Revenue in Ocular Gene Therapy Business (2019-2024) & (US$ Million)

Table 56. MeriaGTx Recent Development

Table 57. Regenxbio Company Details

Table 58. Regenxbio Business Overview

Table 59. Regenxbio Ocular Gene Therapy Product

Table 60. Regenxbio Revenue in Ocular Gene Therapy Business (2019-2024) & (US$ Million)

Table 61. Regenxbio Recent Development

Table 62. GenSight Biologics Company Details

Table 63. GenSight Biologics Business Overview

Table 64. GenSight Biologics Ocular Gene Therapy Product

Table 65. GenSight Biologics Revenue in Ocular Gene Therapy Business (2019-2024) & (US$ Million)

Table 66. GenSight Biologics Recent Development

Table 67. Astellas Company Details

Table 68. Astellas Business Overview

Table 69. Astellas Ocular Gene Therapy Product

Table 70. Astellas Revenue in Ocular Gene Therapy Business (2019-2024) & (US$ Million)

Table 71. Astellas Recent Development

Table 72. Neurophth Therapeutics Company Details

Table 73. Neurophth Therapeutics Business Overview

Table 74. Neurophth Therapeutics Ocular Gene Therapy Product

Table 75. Neurophth Therapeutics Revenue in Ocular Gene Therapy Business (2019-2024) & (US$ Million)

Table 76. Neurophth Therapeutics Recent Development

Table 77. Innostellar Biotherapeutics Company Details

Table 78. Innostellar Biotherapeutics Business Overview

Table 79. Innostellar Biotherapeutics Ocular Gene Therapy Product

Table 80. Innostellar Biotherapeutics Revenue in Ocular Gene Therapy Business (2019-2024) & (US$ Million)

Table 81. Innostellar Biotherapeutics Recent Development

Table 82. Exegenesis Bio Company Details

Table 83. Exegenesis Bio Business Overview

Table 84. Exegenesis Bio Ocular Gene Therapy Product

Table 85. Exegenesis Bio Revenue in Ocular Gene Therapy Business (2019-2024) & (US$ Million)

Table 86. Exegenesis Bio Recent Development

Table 87. Zhongyin Technology Company Details

Table 88. Zhongyin Technology Business Overview

Table 89. Zhongyin Technology Ocular Gene Therapy Product

Table 90. Zhongyin Technology Revenue in Ocular Gene Therapy Business (2019-2024) & (US$ Million)

Table 91. Zhongyin Technology Recent Development

Table 92. Research Programs/Design for This Report

Table 93. Key Data Information from Secondary Sources

Table 94. Key Data Information from Primary Sources

Table 95. Authors List of This Report

List of Figures

Figure 1. Ocular Gene Therapy Picture

Figure 2. Global Ocular Gene Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Ocular Gene Therapy Market Share by Type: 2023 VS 2030

Figure 4. Gene Replacement Technology Features

Figure 5. Gene Editing Technology Features

Figure 6. Others Features

Figure 7. Global Ocular Gene Therapy Market Size by Application (2024-2030) & (US$ Million)

Figure 8. Global Ocular Gene Therapy Market Share by Application: 2023 VS 2030

Figure 9. Hospitals Case Studies

Figure 10. Diagnostics Centers Case Studies

Figure 11. Research Institutes Case Studies

Figure 12. Ocular Gene Therapy Report Years Considered

Figure 13. Global Ocular Gene Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Ocular Gene Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Ocular Gene Therapy Market Share by Region: 2023 VS 2030

Figure 16. Global Ocular Gene Therapy Market Share by Players in 2023

Figure 17. Global Top Ocular Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ocular Gene Therapy as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Ocular Gene Therapy Revenue in 2023

Figure 19. North America Ocular Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Ocular Gene Therapy Market Share by Country (2019-2030)

Figure 21. United States Ocular Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Ocular Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Ocular Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Ocular Gene Therapy Market Share by Country (2019-2030)

Figure 25. Germany Ocular Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Ocular Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Ocular Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Ocular Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Ocular Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Ocular Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Ocular Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Ocular Gene Therapy Market Share by Region (2019-2030)

Figure 33. China Ocular Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Ocular Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Ocular Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Ocular Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Ocular Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Ocular Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Ocular Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Ocular Gene Therapy Market Share by Country (2019-2030)

Figure 41. Mexico Ocular Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Ocular Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Ocular Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Ocular Gene Therapy Market Share by Country (2019-2030)

Figure 45. Turkey Ocular Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Ocular Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. UAE Ocular Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. AbbVie Revenue Growth Rate in Ocular Gene Therapy Business (2019-2024)

Figure 49. MeriaGTx Revenue Growth Rate in Ocular Gene Therapy Business (2019-2024)

Figure 50. Regenxbio Revenue Growth Rate in Ocular Gene Therapy Business (2019-2024)

Figure 51. GenSight Biologics Revenue Growth Rate in Ocular Gene Therapy Business (2019-2024)

Figure 52. Astellas Revenue Growth Rate in Ocular Gene Therapy Business (2019-2024)

Figure 53. Neurophth Therapeutics Revenue Growth Rate in Ocular Gene Therapy Business (2019-2024)

Figure 54. Innostellar Biotherapeutics Revenue Growth Rate in Ocular Gene Therapy Business (2019-2024)

Figure 55. Exegenesis Bio Revenue Growth Rate in Ocular Gene Therapy Business (2019-2024)

Figure 56. Zhongyin Technology Revenue Growth Rate in Ocular Gene Therapy Business (2019-2024)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Optogenetic Gene Therapy Market Research Report 2024

Global Non viral Vectors Gene Therapy Market Research Report 2025

Global In Vitro Gene Therapy Market Research Report 2025

Global Gene Therapy in Oncology Market Research Report 2024

Global Cell and Gene Therapy Solutions Market Research Report 2025

Global Gene Editing Therapy Market Research Report 2024

Global Viral Vector Based Gene Therapy Market Research Report 2025

Global Gene Therapy Drug Delivery Tube Market Research Report 2024

Global Ophthalmic AAV Gene Therapy Market Research Report 2024

Adeno Associated Virus AAV Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gene Therapy Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hemophilia Gene Therapy Market Research Report 2025

Gene Therapy Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene Cell Therapy CDMO Market Research Report 2024

Gene Therapy Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Viral Vectors Non Viral Vectors and Gene Therapy Manufacturing Market Research Report 2024

Global Nucleic Acid Based Gene Therapeutics Market Research Report 2024

Gene Therapy For Heart Failure Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cell and Gene Therapy CDMO Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions